Skip to content
Trouble finding what you were looking for? We're here to help! Give us a call at 1300 938 637
Trouble finding what you were looking for? We're here to help! Give us a call at 1300 938 637

FlowArt Valve For Bag Access

SKU FLO-AS5010

Original price $2.50 - Original price $250.00
Original price
$250.00
$2.50 - $250.00
Current price $250.00

FlowArt Needle Free Valve For IV Infusion Bag Access.

 

FlowArt® valve for bag access is a bi-directional fluid flow IV bag spike with a needle-free valve that has fully transparent clear housing with an integrated flat silicone seal and internal fluid pathway that protects the patient and nursing staff from exposures. It is used to exchange liquids from serum/drug vials and bags without using needles, and to keep the excess drug/serum in reusable vials.

Quantity: 100 / Box

Product Code: FLO-AS5010

Priming Volume: 0.45mL

Length: 9cm

 

** Photoprotective version available upon request - Please use the Contact page to discuss further. 

 

Features:

  • Fully Transparent Valve
  • Gapless split septum seal
  • Flat closed seal that provides a swabable microbial barrier
  • Suitable for 7 days / 600 activations
  • Enhanced visualisation compared to opaque products
  • Compatible with Luer Slip and Luer Lock syringes
  • Free of PVC, latex and metals.
  • ISO 80369 standard compliant - Small-bore connectors for liquids and gases in healthcare applications
  • ISO 80369-7 standard compliant IV sets using luer lock connections.

Suitable for:

  • Blood Transfusion
  • Lipids
  • Oncology
  • MRI procedures

    Research:

    The prevalence of reported Needle Stick Injuries (NSIs) in Australia per year was estimated to be 18,000 in Australian hospitals alone before the introduction of Safety Engineered Devices (SEDs) [1-2]. Considering this number is only the reported incidences and underreporting in Australian hospitals is estimated to be 40%, [3] this is a significant hindrance in maintaining a safe work environment. There are a number of diseases that can be transmitted through NSI, including the human immunodeficiency virus (HIV), hepatitis B (HBV) and hepatitis C (HCV).  The use of SEDs has been shown to reduce NSIs by up to 31% during a 9-month implementation period. [4]

    1. Cathryn Murphy – (2008), Improved surveillance and mandated use of sharps with engineered sharp injury protections: a national call to action
    2. The Australian Council on Healthcare Standards - (2012) Infection Control version 3.1. Retrospective data in full. Australasian Clinical Indicator Report: 2004—2011. In (13th ed.). Sydney NSW; ACHS.
    3. Australian Safety and Compensation Council – (2008) Occupational Exposures in Australian Nurses. Canberra: Australian Government.
    4. Goris, Ashleigh J., Gemeinhart, Nancy, and Babcock, Hilary M - (2015) “Reducing Needlestick Injuries from Active Safety Devices: A Passive Safety Engineered Device Conversion.” AJIC: American Journal of Infection Control 43.6

    Additional Resources

    Request a quote

    Customer Reviews

    Based on 1 review
    100%
    (1)
    0%
    (0)
    0%
    (0)
    0%
    (0)
    0%
    (0)
    M
    Michael Tsai
    Good experience

    Prompt delivery, good customer service